Randomized phase 3 study of panitumumab with FOLFIRI vs FOLFIRI alone as second-line treatment (tx) in patients (pts) with metastatic colorectal cancer (mCRC)

  1. Peeters, M.
  2. Price, T.
  3. Hotko, Y.
  4. Cervantes, A.
  5. Ducreux, M.
  6. Andre, T.
  7. Chan, E.
  8. Lordick, F.
  9. Rong, A.
  10. Gansert, J.
Aldizkaria:
EJC SUPPLEMENTS

ISSN: 1359-6349,  1878-1217

Argitalpen urtea: 2009

Alea: 7

Zenbakia: 3

Orrialdeak: 10-10

Biltzarra: 15th Congress of the European-Cancer-Organization/34th Multidisciplinary Congress of the European-Society-for-Medical-Oncology

Mota: Biltzar ekarpena

DOI: 10.1016/S1359-6349(09)72049-X GOOGLE SCHOLAR
Datuen iturria: WoS